|
|
Blood, 1 December 2007, Vol. 110, No. 12, pp. 4022-4029.
Prepublished online as a Blood First Edition Paper on August 24, 2007; DOI 10.1182/blood-2007-04-082040.
Previous Article | Next Article 
Submitted April 20, 2007
Accepted August 10, 2007
Sub-microscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of 'isolated' and its possible clinical implications
Nikola Hagedorn, Cecile Acquaviva, Eva Fronkova, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, Andre Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Gunter Henze, Helene Cave, and Cornelia Eckert*
Department of Pediatric Oncology/Hematology, Charite Medical University Berlin, Berlin, Germany
Laboratoire de Biochimie Genetique -Departement de Genetique, Hopital Robert Debre (APHP), Paris, France
Department of Pediatric Hematology/Oncology, 2nd Medical School, Charles University Prague, Prague, Czech Republic
Department of Pediatric Hematology/Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Service d'Hematol-immunologie pediatrique, Hopital Robert Debre, Paris, France
* Corresponding author; email: cornelia.eckert{at}charite.de.
This study investigates the extent of bone marrow (BM) involvement at diagnosis of apparent isolated extramedullary (AIEM) relapses of childhood acute lymphoblastic leukemia (ALL), and its relation to prognosis. Sixty-four children with first AIEM relapse treated in Germany, Czech Republic or France were included. Real-time quantitative polymerase-chain-reaction using T-cell-receptor and immunoglobulin gene rearrangements provided a sensitive measure of sub-microscopic BM involvement, which was detectable at a level of 10-4 in 46, <10-4 in 11, and non-detectable (sensitivity:10-4) in 7 patients. In the total cohort, the probability of event-free survival (pEFS) for children with BM involvement 10-4 was 0.30 (standard error [SE] ±0.09) versus 0.60 (SE±0.12) for those with <10-4 (p=0.13). The cumulative incidence of subsequent relapse was 0.24 (SE±0.01) for patients with BM involvement <10-4 and 0.65 (SE±0.01) for those with 10-4 (p=0.012). Restricted to central nervous system (CNS) relapses, pEFS was 0.11 (SE±0.09) for patients with BM involvement 10-4 and 0.63 (SE±0.17) for those with <10-4 (p=0.053). CNS relapses were associated with a higher ( 10-4: 80%) sub-microscopic BM involvement than testicular relapses ( 10-4:57%, p=0.08). In summary, we show marked heterogeneity of sub-microscopic BM involvement at first AIEM relapse diagnosis in children with ALL, and demonstrate its possible prognostic relevance.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C.-H. Pui, D. Campana, D. Pei, W. P. Bowman, J. T. Sandlund, S. C. Kaste, R. C. Ribeiro, J. E. Rubnitz, S. C. Raimondi, M. Onciu, et al.
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
N. Engl. J. Med.,
June 25, 2009;
360(26):
2730 - 2741.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|